Alpha-galactosidase A — Drug Target
All drugs that target Alpha-galactosidase A — marketed and clinical-stage. Includes 1 drug classes acting on this target.
Drug classes
Marketed (2)
- agalsidase beta (GZ419828) · Sanofi · Enzyme replacement therapy · Rare genetic disease / Lysosomal storage disorder
Agalsidase beta is a recombinant human alpha-galactosidase A enzyme that breaks down globotriaosylceramide (Gb3) accumulation in cells. - Galafold · Amicus Therap Us · Metabolic
Galafold stabilizes the alpha-galactosidase A enzyme to treat Fabry's disease.